Global Biochips Market Analysis Report, 2016-2019 and Forecast to 2025 - Product Types, Fabrication Technologies, End-User Sectors

DUBLIN, Sept. 24, 2019 /PRNewswire/ -- The "Biochips - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.

The report reviews, analyzes and projects the global biochips market for the period 2016-2025 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2025.

Research Findings & Coverage

• The global market research report on Biochips analyzes the global market with respect to by product types, fabrication technologies, and end-user sectors
• Biochips' market size is estimated in this report by product types, fabrication technologies and end-user sectors across all major countries
• Technological Advances in Biochip Enable Next-Generation DNA Sequencing Technologies
• Real Blood Vessels on a Microfluidic Biochip: Organs-on-a-Chip
• MIT Develops Neuromorphic Chip that Can Work Like a Human Brain
• Body-on-a-chip to Aid Next-Generation Drug Testing
• Key business trends focusing on product innovations/developments, M&As, JVs, and other recent industry developments
• Major companies profiled - 28
• The industry guide includes the contact details for 160 companies

Biotechnology & Pharmaceutical Companies constitutes the largest end-user market for Biochips globally, estimated at US$2.8 billion in 2018 and is expected to register a CAGR of 17.6% over 2018-2025 in reaching a projected US$8.8 billion by 2025. The overall global market for Biochips is expected to reach US$8.5 billion in 2019.

The rise in R&D investment, as well as government funding in emerging economies, are expected to provide lucrative growth opportunities for the biochips market. The increase in the prevalence of cancer, immunological disorders, and viral infections majorly drive the growth of the global biochips market.

Other factors that boost the market growth include the rise in the geriatric population, the increase in the number of biochip applications and the high adoption of personalized medications. On the other hand, a lack of technical knowledge related to biochips is a prominent restraint lowering the demand for biochip products.

Key Topics Covered

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Introduction to Biochips
1.1.2 Definition of Biochip
1.1.3 History behind Invention of Biochip
1.1.4 Components of Biochips
1.1.4.1 Transponder
1.1.4.1.1 Computer microchip
1.1.4.1.2 Antenna Coil
1.1.4.1.3 Tuning Capacitor
1.1.4.1.4 Glass Capsule
1.1.4.2 Reader
1.1.5 Working Principle of a Biochip
1.1.6 Quality Standards for Medical Devices
1.1.7 Biochips Fabrication Technology
1.1.7.1 Microarrays
1.1.7.2 Microfluidics
1.1.8 Types of Biochips
1.1.8.1 DNA chip
1.1.8.1.1 Applications of DNA biochip
1.1.8.2 Lab-on-a chip
1.1.8.2.1 Applications of Lab-on-a chip
1.1.8.2.1.1 Lab-on-a-chip and Molecular Biology
1.1.8.2.1.2 Lab-on-a-chip and Proteomics
1.1.8.2.1.3 Lab-on-a-chip and Cell Biology
1.1.8.2.1.4 Lab-on-a-chip and Chemistry
1.1.8.3 Protein chip
1.1.8.3.1 Types of Protein Microarrays
1.1.8.3.1.1 Analytical Microarrays:
1.1.8.3.1.2 Functional Protein Microarrays:
1.1.8.3.1.3 Reverse Phase Protein Microarray (RPPA):
1.1.8.3.2 Applications of Protein Biochip
1.1.8.4 Other Biochips
1.1.8.4.1 Cell Biochip
1.1.8.4.1.1 Types of Cell Biochips
1.1.8.4.1.2 Applications of Cell Biochips
1.1.8.4.2 Tissue Arrays
1.1.8.4.2.1 Applications of Tissue Arrays
1.1.9 Applications of Biochips
1.1.9.1 Medicinal Implementations of Biochips
1.1.9.1.1 Biochips as Glucose Detector
1.1.9.1.2 Biochip as Oxygen Sensor
1.1.9.1.3 Biochip as Blood Pressure Sensor
1.1.9.2 Biochip for Diagnosis and Prediction of Diseases
1.1.9.3 Biochips for Drug Discovery and Development
1.1.9.4 Biochips for Drug of Abuse Test
1.1.9.5 Biochip and Cancer
1.1.9.6 Biochips for Characterizing and Quantifying Bimolecular
1.1.9.7 Biochip Development for Polymorphism Analysis in Biotransformation System Genes
1.1.9.8 Biochip to Identify Biowarfare Agents
1.1.9.9 Biochips for Department of Defense

2. KEY MARKET TRENDS
2.1 Technological Advances in Biochip Enable Next-Generation DNA Sequencing Technologies
2.2 The New Biochip Detects Minute Levels of Disease with a Blood Test
2.3 Real Blood Vessels on a Microfluidic Biochip: Organs-on-a -Chip
2.4 MIT Develops Neuromorphic Chip That Can Work Like a Human Brain
2.5 Surface Acoustic Waves Orchestrate Neuronal Cells on a Biochip
2.6 Multiplexed Identification of Drug-Resistant Pathogens by Using a Miniaturized Semiconductor Biochip
2.7 Tiny Biochip Developed for Fast, Accurate and Low-Cost Disease Detection
2.8 Scientists Devise Nanoscale 3D Printing Technique for Imprinting Biochips
2.9 Body-on-a-chip to Aid Next-Generation Drug Testing
2.10 Silicon Lab-on-a-Chip to Stretch Double-Stranded DNA Molecules for Disease Detection
2.11 Risk of Alzheimer's disease Detected with a New Biochip-Based Blood Test in 3 Hours

3. KEY GLOBAL PLAYERS

• Abbott Laboratories (The United States)
• Agilent Technologies, Inc. (The United States)
• Beckman Coulter, Inc. (The United States)
• Bio-Rad Laboratories, Inc. (The United States)
• Cepheid, Inc. (The United States)
• F. Hoffmann-La Roche Ag (Switzerland)
• GE Healthcare, Ltd. (The United Kingdom)
• Illumina, Inc. (The United States)
• Perkinelmer, Inc. (The United States)
• Qiagen N.V. (The Netherlands)
• Thermo Fisher Scientific, Inc. (The United States)
• Affymetrix, Inc. (The United States)

4. KEY BUSINESS & PRODUCT TRENDS

• Agilent Technologies, Inc Unveils InfinityLab Liquid Chromatography/Mass Selective Detector iQ (LC/MSD iQ)
• Thermo Fisher Acquires HighChem LLC, Slovakia
• Thermo Fisher Develops New Sensititre ARIS HiQ AST System
• Thermo Fisher and Evosep Join Hands to Develop Clinical Research Proteomics Workflows for Research and Pharmaceutical Applications
• Agilent Technologies, Inc Showcase Advance Immunotherapy Portfolio at American Association of Immunologists (AAI) California
• Merck KGaA Invests in Irvine Facility
• Fluidigm Corporation Launches Advanta RNA Fusions NGS Library Prep Assay to lead Clinical Cancer Research
• Samsung Develops New Exynos I Chips
• Roche Group Unveils VENTANA HER2 Dual ISH DNA Probe Cocktail Assay for Cancer Therapy
• QIAGEN NV Selects NeuMoDx Molecular, Inc for CE-IVD Assays Purchase
• Thermo Fisher Launches new Microscope - The Helios 5 DualBeam FIB-SEM
• FDA Approval for Bio-Rad's QXDx AutoDG ddPCR System and QXDx BCR-ABL %IS Kit
• Fluidigm Corporation and Indica Labs, Inc Enter Co-Marketing Agreement to Promote Digital Pathology Investigations
• Illumina, Inc Unveils New Infinium Global Diversity Array
• USDA FSIS Select Bio-Rad for iQ-Check real-time PCR Pathogen Detection
• Illumina, Inc to Acquire Pacific Biosciences of California, Inc
• QIAGEN NV Unveils DNeasy Plant Pro Kit for DNA Use
• FDA Approval for Bio-Rad's IH-Reader 24, Blood Typing Instrument
• Roche Group Unveils NGS AVENIO Tumor Tissue Analysis Kits for Oncology Research
• Illumina Develops New TruSightTM Oncology 500 (TSO 500) Pan-Cancer Assay
• Fluidigm and GenomOncology Join Hands to Offer Immuno-Oncology Gene Expression Solutions
• FDA Approval for Cepheid's Xpert Xpress Flu/RSV Test
• Beckman Coulter's Access Sensitive Estradiol Assay Receives license by Health Canada to Aid in Reproductive Health Management
• Illumina, Inc Acquires Edico Genome, Inc
• Fluidigm Launches High-Parameter Maxpar Immune Monitoring Panel for Clinical Research
• Merck KGaA and Incheon Free Economic Zone (IFEZ) Collaborate to Establish Cell Culture Facility in Songdo, Incheon
• Emulate, Inc and Roche Join hands on Drug Discovery Platform Human Emulation System
• Thermo Fisher Launches NGS Ion GeneStudio S5 Series Instrument for Disease Research Use
• Merck and Samsung Biologics Sign Memorandum of Understanding on Biopharmaceutical Production and Biological process Development
• Illumina, Inc. Launches NextSeq 550Dx Instrument
• Roche Group Presents Cancer Immunotherapy Progression at the European Society for Medical Oncology Congress, Spain
• Merck to Acquire Natrix
• Fluidigm Enter into Partnership with Ascendas Genomics to Develop Microfluidic Molecular Diagnostics in China
• Bio-Rad Receives FDA Clearance for its BioPlex 2200 Syphilis Total & RPR Assay
• DiaSorin and QIAGEN NV Join Hands to Develop LIAISON Test Menu
• Thermo Fisher Unveils Ion AmpliSeq Next-Generation Sequencing (NGS) Line of Assays
• Illumina and Royal Philip Collaborate on Genomic Solution
• PerkinElmer, Inc Unveils Vectra Polaris Automated Quantitative Pathology Imaging System
• QIAGEN NV Develops Enhancements for the GeneReader NGS System
• Celgene to Acquire Delinia

5. GLOBAL MARKET OVERVIEW
5.1 Global Biochips Market Overview by Product Type
5.1.1 Biochips Product Market Overview by Global Region
5.1.1.1 DNA Chip
5.1.1.2 Lab-on-a-Chip
5.1.1.3 Protein Chip
5.1.1.4 Other Biochips
5.2 Global Biochips Market Overview by Fabrication Technology
5.2.1 Biochips Fabrication Technology Market Overview by Global Region
5.2.1.1 Microarrays
5.2.1.2 Microfluidics
5.3 Global Biochips Market Overview by End User
5.3.1 Biochips End User Market Overview by Global Region
5.3.1.1 Biotechnology & Pharmaceutical
5.3.1.2 Academic & Research Institutes
5.3.1.3 Hospitals & Diagnostics Centers

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

Major Market Players

• Abbott Laboratories (The United States)
• Agilent Technologies, Inc. (The United States)
• Beckman Coulter, Inc. (The United States)
• Biochain Institute, Inc. (The United States)
• Bio-Rad Laboratories, Inc. (The United States)
• Celgene Corporation (The United States)
• Cepheid, Inc. (The United States)
• Fluidigm Corporation (The United States)
• Illumina, Inc. (The United States)
• Li-Cor, Inc. (The United States)
• Milliporesigma (The United States)
• Novus Biologicals, LLC (The United States)
• Origene Technologies, Inc. (The United States)
• Perkinelmer, Inc. (The United States)
• Stemcell Technologies, Inc. (Canada)
• Thermo Fisher Scientific, Inc. (The United States)
• Affymetrix, Inc. (The United States)
• US Biomax, Inc. (The United States)

7. EUROPE

Major Market Players

• Biomerieux SA (France)
• F. Hoffmann-La Roche AG (Switzerland)
• Gamida France (France)
• GE Healthcare, Ltd. (The United Kingdom)
• Merck KGaA (Germany)
• Qiagen N.V. (The Netherlands)
• Randox Laboratories, Ltd. (The United Kingdom)

8. ASIA-PACIFIC

Major Market Players

• Horiba, Ltd. (Japan)
• Samsung Electronics Co., Ltd. (South Korea)
• Superbiochips Laboratories (South Korea)

9. SOUTH AMERICA

10. REST OF WORLD

For more information about this report visit https://www.researchandmarkets.com/r/mbd15o

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-biochips-market-analysis-report-2016-2019-and-forecast-to-2025---product-types-fabrication-technologies-end-user-sectors-300924183.html

SOURCE Research and Markets